Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma

Antoni Ribas; Caroline Robert; Adil Daud; F. Stephen Hodi; Jedd D. Wolchok; Richard Kefford; Amita Patnaik; Wen-Jen Hwu; Jeffrey S. Weber; Anthony Joshua; Peter Hersey; Tara C. Gangadhar; Richard Wayne Joseph; Roxana Stefania Dronca; Hassane M. Zarour; Scot Ebbinghaus; Kevin Gergich; Xiaoyun (Nicole) Li; Soonmo Peter Kang; Omid Hamid

doi:10.1200/jco.2013.31.15_suppl.9009

Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma

Antoni Ribas, Caroline Robert, Adil Daud, F. Stephen Hodi, Jedd D. Wolchok, Richard Kefford, Amita Patnaik, Wen-Jen Hwu, Jeffrey S. Weber, Anthony Joshua, Peter Hersey, Tara C. Gangadhar, Richard Wayne Joseph, Roxana Stefania Dronca, Hassane M. Zarour, Scot Ebbinghaus, Kevin Gergich, Xiaoyun (Nicole) Li, Soonmo Peter Kang, Omid Hamid

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	9009-9009
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	31
Issue number	15 supplement
DOIs	https://doi.org/10.1200/jco.2013.31.15_suppl.9009
Publication status	Published - 20 May 2013
Event	Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duration: 31 May 2013 → 4 Jun 2013

Cite this

Ribas, A., Robert, C., Daud, A., Hodi, F. S., Wolchok, J. D., Kefford, R., ... Hamid, O. (2013). Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma. Journal of Clinical Oncology, 31(15 supplement), 9009-9009. https://doi.org/10.1200/jco.2013.31.15_suppl.9009

Ribas, Antoni ; Robert, Caroline ; Daud, Adil ; Hodi, F. Stephen ; Wolchok, Jedd D. ; Kefford, Richard ; Patnaik, Amita ; Hwu, Wen-Jen ; Weber, Jeffrey S. ; Joshua, Anthony ; Hersey, Peter ; Gangadhar, Tara C. ; Joseph, Richard Wayne ; Dronca, Roxana Stefania ; Zarour, Hassane M. ; Ebbinghaus, Scot ; Gergich, Kevin ; Li, Xiaoyun (Nicole) ; Kang, Soonmo Peter ; Hamid, Omid. / Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma. In: Journal of Clinical Oncology. 2013 ; Vol. 31, No. 15 supplement. pp. 9009-9009.

@article{2161ccee2538488d8db5f464e4c9ef13,

title = "Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma",

author = "Antoni Ribas and Caroline Robert and Adil Daud and Hodi, {F. Stephen} and Wolchok, {Jedd D.} and Richard Kefford and Amita Patnaik and Wen-Jen Hwu and Weber, {Jeffrey S.} and Anthony Joshua and Peter Hersey and Gangadhar, {Tara C.} and Joseph, {Richard Wayne} and Dronca, {Roxana Stefania} and Zarour, {Hassane M.} and Scot Ebbinghaus and Kevin Gergich and Li, {Xiaoyun (Nicole)} and Kang, {Soonmo Peter} and Omid Hamid",

year = "2013",

month = "5",

day = "20",

doi = "10.1200/jco.2013.31.15_suppl.9009",

language = "English",

volume = "31",

pages = "9009--9009",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "American Society of Clinical Oncology",

number = "15 supplement",

}

Ribas, A, Robert, C, Daud, A, Hodi, FS, Wolchok, JD, Kefford, R, Patnaik, A, Hwu, W-J, Weber, JS, Joshua, A, Hersey, P, Gangadhar, TC, Joseph, RW, Dronca, RS, Zarour, HM, Ebbinghaus, S, Gergich, K, Li, XN, Kang, SP & Hamid, O 2013, 'Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma', Journal of Clinical Oncology, vol. 31, no. 15 supplement, pp. 9009-9009. https://doi.org/10.1200/jco.2013.31.15_suppl.9009

Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma. / Ribas, Antoni; Robert, Caroline; Daud, Adil; Hodi, F. Stephen; Wolchok, Jedd D.; Kefford, Richard; Patnaik, Amita; Hwu, Wen-Jen; Weber, Jeffrey S.; Joshua, Anthony; Hersey, Peter; Gangadhar, Tara C.; Joseph, Richard Wayne; Dronca, Roxana Stefania; Zarour, Hassane M.; Ebbinghaus, Scot; Gergich, Kevin; Li, Xiaoyun (Nicole); Kang, Soonmo Peter; Hamid, Omid.

In: Journal of Clinical Oncology, Vol. 31, No. 15 supplement, 20.05.2013, p. 9009-9009.

Research output: Contribution to journal › Meeting abstract

TY - JOUR

T1 - Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma

AU - Ribas, Antoni

AU - Robert, Caroline

AU - Daud, Adil

AU - Hodi, F. Stephen

AU - Wolchok, Jedd D.

AU - Kefford, Richard

AU - Patnaik, Amita

AU - Hwu, Wen-Jen

AU - Weber, Jeffrey S.

AU - Joshua, Anthony

AU - Hersey, Peter

AU - Gangadhar, Tara C.

AU - Joseph, Richard Wayne

AU - Dronca, Roxana Stefania

AU - Zarour, Hassane M.

AU - Ebbinghaus, Scot

AU - Gergich, Kevin

AU - Li, Xiaoyun (Nicole)

AU - Kang, Soonmo Peter

AU - Hamid, Omid

PY - 2013/5/20

Y1 - 2013/5/20

U2 - 10.1200/jco.2013.31.15_suppl.9009

DO - 10.1200/jco.2013.31.15_suppl.9009

M3 - Meeting abstract

VL - 31

SP - 9009

EP - 9009

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 1527-7755

IS - 15 supplement

ER -

Access to Document

10.1200/jco.2013.31.15_suppl.9009